VIP
Central Nervous System Diseases
Danish Headache Centerprotein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
22 Active assets in the Central Nervous System Diseases cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Live Combined Bifidobacterium Beijing Friendship Hospital | Phase 4 | BB |
3-N-BUTYLPHTHALIDE Qianfoshan Hospital | Phase 4 | BB |
Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules Beijing Friendship Hospital | Phase 4 | BB |
Donanemab Eli Lilly and Company | Phase 3 | BB |
ENCENICLINE FORUM Pharmaceuticals Inc | Phase 2 | BB |
View all 50 →
Same molecule, other indications
VIP is also rated in:
Healthy Volunteers, Headache, Migraine, Hemodynamics, VIP, SPECT, UltrasoundDormant
D
Indicative ·
30 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →